TipRanks
TipRanksTop Financial ExpertsInsidersJennifer Jarrett

Jennifer Jarrett Insider Profile

11 Followers
Jennifer Jarrett, Director, President and CEO, Director at Damora Therapeutics, holds 512.50K shares in Damora Therapeutics (Ticker: DMRA), holds 114.00K shares in Syndax Pharmaceuticals (Ticker: SNDX), holds 224.02K shares in Arcus Biosciences (Ticker: RCUS). Most recently, Jennifer Jarrett Bought ― shares of Damora Therapeutics on Sep 28, 2026 for an estimated value of $252.88K.
See the Hottest Stocks Based on Insider Trading >
tipranks
Jennifer Jarrett

Jennifer Jarrett
Damora Therapeutics (DMRA)
Director, President and CEO, Director

Ranked #7,118 out of 109,349 Corporate Insiders

Profitable Transactions

75%
9 out of 12 Profitable Transactions

Average Return

+23.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$18M
62.88%
23.26%
8.88%
4.97%
0.00% Others
A breakdown of Jennifer Jarrett's holdings
See the Top Stocks by Insiders

Insider Roles

Damora Therapeutics
(DMRA)
Director, President and CEO, Director
Arcus Biosciences
(RCUS)
COO
Syndax Pharmaceuticals
(SNDX)
Director
Surrozen
(SRZN)
Former Director
+2 other positions
Roles that Jennifer Jarrett holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Arcus Biosciences
(RCUS)
Rating:Informative Sell
Date:Mar 18, 2022 - Mar 18, 2023
Return:+54.20%
The most profitable trade made by Jennifer Jarrett
See the Latest Stocks Traded by Insiders

Jennifer Jarrett's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
DMRA
Damora Therapeutics
Sep 28, 2026
Director, President and CEO, Director
Informative Buy
252.88K
$11.01M
MDVN
Medivation
Sep 30, 2016
―
Uninformative Sell
―
$0.00
ARNA
Arena Pharma
Mar 11, 2022
―
Uninformative Sell
―
$0.00
~BOLD
Audentes Therapeutics
―
―
―
―
RCUS
Arcus Biosciences
Jan 26, 2026
COO
Uninformative Buy
―
$4.07M
SNDX
Syndax Pharmaceuticals
Feb 06, 2026
Director
Uninformative Buy
―
$1.56M
SRZN
Surrozen
Aug 13, 2021
Former Director
Uninformative Buy
―
$871.20K
~RDUS
Radius Health
―
―
―
―
ZURA
Zura Bio
―
Director
―
―
SGMT
Sagimet Biosciences, Inc. Class A
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Jennifer Jarrett's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Jennifer Jarrett insider profile FAQ

What is the percentage of profitable transactions made by Jennifer Jarrett?
The percentage of profitable transactions made by Jennifer Jarrett is 75%.
    What is the average return per transaction made by Jennifer Jarrett?
    The average return per transaction made by Jennifer Jarrett is 23.20%.
      What stocks does Jennifer Jarrett hold?
      Jennifer Jarrett holds: DMRA, MDVN, ARNA, ~BOLD, RCUS, SNDX, SRZN, ~RDUS, ZURA, SGMT stocks.
        What was Jennifer Jarrett’s latest transaction?
        Jennifer Jarrett latest transaction was an Informative Buy of $252.88K.
          What was Jennifer Jarrett's most profitable transaction?
          Jennifer Jarrett’s most profitable transaction was an Informative Sell of RCUS stock on March 18, 2022. The return on the trade was 54.20%.
            What is Jennifer Jarrett's role in Damora Therapeutics?
            Jennifer Jarrett's role in Damora Therapeutics is Director, President and CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.